The Drug Controller General of India(DCGI) has given Emergency Use Authorization (EUA) to the Two vaccines on the basis of safety and immunogenicity, COVISHIELD from Serum Institute of India (SII) & COVAXIN of Bharat BioTech (BBIL). The Government of India has purchased 110 lakh vaccines from SII at the cost of Rs.200/dose(excluding taxes) and 55 lakh Vaccines of COVAXIN are being procured from BBIL. The cost of 38.5 lakh doses is Rs 296/dose (excluding taxes).
The other vaccines that are in the pipeline are Zydus Cadila that has completed Phase-2 clinical rials and will be starting Phase -3 trials, Sputnik V Phase-2 & 3 trials ongoing, Biological E Phase -1 trails ongoing and Gennova Phase -1 trials approved.
Tea And Cigarette Side Effects: Do you have the habit of smoking cigarettes with tea?…
Benefits of Roasted Chana: 6 Amazing Benefits of Roasted Chana in Peel: Aids weight loss,…
Ways to increase male fertility;This seed can prove to be very effective in increasing the…
Explore 10 effective natural remedies that can complement your rheumatoid arthritis treatment plan and help…
In our fast-paced lives, it’s easy to overlook our mental and emotional well-being. However, recent…
Breast cancer remains a significant global health challenge, affecting millions of women each year. According…